Previous studies reported that ×4 viral strains can infect CD34+ HSC [81], so that delivery of a protective gene construct (containing a C46 inhibitor that inhibits ×4 infection) to CD34+ HSC is likely to confer an additional survival advantage on G+ CD34+ HSC. This evidence concerns the gene CD34 and infection.